Drug
1L PEG-Asc
1L PEG-Asc is a pharmaceutical drug with 3 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Total Trials
3
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 2 completed trials
Completion Rate
100%(2/2)
Active Trials
1(33%)
Results Posted
0%(0 trials)
Phase Distribution
Ph not_applicable
2
67%
Ph phase_3
1
33%
Phase Distribution
0
Early Stage
0
Mid Stage
1
Late Stage
Phase Distribution3 total trials
Phase 3Large-scale testing
1(33.3%)
N/ANon-phased studies
2(66.7%)
Highest Phase Reached
Phase 3Trial Status & Enrollment
Completion Rate
100.0%
2 of 2 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
1
trials recruiting
Total Trials
3
all time
Status Distribution
Active(1)
Completed(2)
Detailed Status
Completed2
Recruiting1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
1
Success Rate
100.0%
Most Advanced
Phase 3
Trials by Phase
Phase 31 (33.3%)
N/A2 (66.7%)
Trials by Status
completed267%
recruiting133%
Recent Activity
1 active trials
Showing 3 of 3
recruitingphase_3
Clinical Trial on Bowel Preparation Comparing Mannitol 100g to Plenvu Both in a Same Day Regimen (CLEARWAY)
NCT07465705
completednot_applicable
Efficacy And Tolerability Of Asymmetric Split Regimen For Bowel Preparation
NCT06916689
completednot_applicable
Effectiveness of Bisacodyl Suppository Agent for Dose Reduction of Low Dose PEG
NCT03849196
Clinical Trials (3)
Showing 3 of 3 trials
NCT07465705Phase 3
Clinical Trial on Bowel Preparation Comparing Mannitol 100g to Plenvu Both in a Same Day Regimen (CLEARWAY)
NCT06916689Not Applicable
Efficacy And Tolerability Of Asymmetric Split Regimen For Bowel Preparation
NCT03849196Not Applicable
Effectiveness of Bisacodyl Suppository Agent for Dose Reduction of Low Dose PEG
All 3 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 3